Jordi Alberch
Jordi Alberch
Catedratico, Departamento de Biomedicina, Universidad de Barcelona
Verified email at
Cited by
Cited by
Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ...
EMBO molecular medicine 4 (5), 380-395, 2012
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
JM Canals, JR Pineda, JF Torres-Peraza, M Bosch, R Martín-Ibañez, ...
Journal of Neuroscience 24 (35), 7727-7739, 2004
Heterochronic mechanisms of morphological diversification and evolutionary change in the neotropical salamander, Bolitoglossa occidentalis (Amphibia …
P Alberch, J Alberch
Journal of Morphology 167 (2), 249-264, 1981
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase
M Borrell-Pagès, JM Canals, FP Cordelières, JA Parker, JR Pineda, ...
The Journal of clinical investigation 116 (5), 1410-1424, 2006
Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration
M Díaz-Hernández, M Díez-Zaera, J Sánchez-Nogueiro, ...
The FASEB Journal 23 (6), 1893-1906, 2009
Differential effects of glial cell line‐derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons
P Åkerud, J Alberch, S Eketjäll, J Wagner, E Arenas
Journal of neurochemistry 73 (1), 70-78, 1999
Brain‐derived neurotrophic factor, neurotrophin‐3, and neurotrophin‐4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease
E Pérez‐Navarro, AM Canudas, P Åkerud, J Alberch, E Arenas
Journal of neurochemistry 75 (5), 2190-2199, 2000
Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells
HTJ Mount, DO Dean, J Alberch, CF Dreyfus, IB Black
Proceedings of the National Academy of Sciences 92 (20), 9092-9096, 1995
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
C Blázquez, A Chiarlone, O Sagredo, T Aguado, MR Pazos, E Resel, ...
Brain 134 (1), 119-136, 2011
Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus
D Del Toro, J Alberch, F Lázaro-Diéguez, R Martín-Ibáñez, X Xifro, ...
Molecular biology of the cell 20 (5), 1478-1492, 2009
BDNF up‐regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia
I Ferrer, J Ballabriga, E Martí, E Pérez, J Alberch, E Arenas
Brain pathology 8 (2), 253-261, 1998
The expanding clinical profile of anti-AMPA receptor encephalitis
F Graus, A Boronat, X Xifro, M Boix, V Svigelj, A Garcia, A Palomino, ...
Neurology 74 (10), 857-859, 2010
Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease
J Alberch, E Perez-Navarro, JM Canals
Brain research bulletin 57 (6), 817-822, 2002
Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity
A Giralt, M Puigdellivol, O Carretón, P Paoletti, J Valero, A Parra-Damas, ...
Human molecular genetics 21 (6), 1203-1216, 2012
Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum
E Arenas, J Alberch, E Perez-Navarro, C Solsona, J Marsal
Journal of Neuroscience 11 (8), 2332-2338, 1991
Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area
JM Canals, N Checa, S Marco, P Åkerud, A Michels, E Pérez-Navarro, ...
Journal of Neuroscience 21 (1), 117-124, 2001
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
S Ginés, M Bosch, S Marco, N Gavalda, M Díaz‐Hernández, JJ Lucas, ...
European Journal of Neuroscience 23 (3), 649-658, 2006
Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5
P Paoletti, I Vila, M Rifé, JM Lizcano, J Alberch, S Ginés
Journal of Neuroscience 28 (40), 10090-10101, 2008
Neurotrophic factors in Huntington's disease
J Alberch, E Pérez-Navarro, JM Canals
Progress in brain research 146, 197-229, 2004
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease
A Giralt, A Saavedra, O Carretón, X Xifró, J Alberch, E Pérez-Navarro
Human molecular genetics 20 (21), 4232-4247, 2011
The system can't perform the operation now. Try again later.
Articles 1–20